Quantcast
Last updated on April 17, 2014 at 8:20 EDT

Latest China Biologic Products Inc. Stories

2014-04-02 08:33:29

BEIJING, April 2, 2014 /PRNewswire/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company has learned that the pending claim in the High Court of Hong Kong (the "Court") against Ms. Siu Ling Chan ("Ms. Chan"), an individual shareholder of the Company, and her spouse, Mr. Tung Lam, had been withdrawn with Court approval. The claim was originally...

2014-03-19 08:29:30

BEIJING, March 19, 2014 /PRNewswire/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company has received the Good Manufacturing Practice ("GMP") certification from China Food and Drug Administration ("CFDA") in respect of its plasma production facility at its Guizhou subsidiary. Mr. David (Xiaoying) Gao, Chairman and Chief Executive Officer of...

2014-03-04 08:30:51

BEIJING, March 4, 2014 /PRNewswire/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company plans to release fourth quarter and fiscal year 2013 financial results on Wednesday, March 12, 2014 after the market closes. The Company's management will hold a conference call at 8:00 a.m. ET on Thursday, March 13, 2014, which is 8:00 p.m., Beijing Time on...

2014-03-03 08:30:17

BEIJING, March 3, 2014 /PRNewswire/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company has completed its repurchase of 2.5 million shares of common stock for a total consideration of $70 million. This transaction was originally announced in the Company's 8-K SEC filing on January 28, 2014. Mr. David (Xiaoying) Gao, Chairman and Chief...

2013-12-30 23:00:35

ChinaMarketResearchReports.com adds “China Blood Product Industry Report, 2012-2015” Latest Report to its store. Dallas, TX (PRWEB) December 31, 2013 Plasma is a key raw material of the blood product industry. In August 2011, China shut down 16 plasma stations in Guizhou, resulting in a decrease of 15% in the plasma volume of the year. However, due to the implementation of favorable policies, widening gap between supply and demand, rising product prices and other factors, more than...

2013-10-28 16:25:03

BEIJING, Oct. 28, 2013 /PRNewswire-FirstCall/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company plans to release third quarter 2013 financial results on Tuesday, November 5, 2013 after the market closes. The Company's management will hold a conference call at 7:30 a.m. ET on Wednesday, November 6, 2013, which is 8:30 p.m., Beijing Time on...

2013-08-29 08:24:39

BEIJING, Aug. 29, 2013 /PRNewswire-FirstCall/ -- China Biologic Products, Inc. (Nasdaq: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, is scheduled to participate in the upcoming conferences: -- Credit Suisse Asian Healthcare Conference, to be held September 3, 2013 at the Credit Suisse office at International Commerce Centre, Hong Kong. Management is scheduled to meet with institutional investors...

2013-08-06 16:29:20

2Q13 Total Sales Up 6.2% / 1H Total Sales Up 10.2% BEIJING, Aug. 6, 2013 /PRNewswire-FirstCall/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced its unaudited financial results for the second quarter of 2013. Second Quarter 2013 Financial Highlights Total sales in the second quarter of 2013 increased by 6.2% to $53.6 million from $50.5 million in the...

2013-07-30 08:33:50

BEIJING, July 30, 2013 /PRNewswire-FirstCall/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company plans to release second quarter 2013 financial results on Tuesday, August 6, 2013 after the market closes. The Company's management will hold a conference call at 7:30 a.m. ET on Wednesday, August 7, 2013 to discuss second quarter 2013 results....

2013-07-04 23:02:57

MarketResearchReports.Biz announces addition of new report “China Blood Product Industry Report, 2012-2015” to its database. Buy the copy of this report visit - http://www.marketresearchreports.biz/analysis-details/china-blood-product-industry-report-2012-2015 Albany, New York (PRWEB) July 04, 2013 Plasma is a key raw material of the blood product industry. On August 2011, China shut down 16 plasma stations in Guizhou, resulting in a decrease of 15% in the plasma volume of the year....